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Abstract
Healthy human skin has beneficial microflora and many pathogens causing infections.
Staphylococcus aureus is the most prevalent and can have multiresistance to antibiotics.
Chitosan is a polysaccharide composed of glucosamine and N-acetyl-D-glucosamine,
which is biodegradable and has antimicrobial activity. As part of a national scientific
research project for the development and application of biomaterials, we decided to study
the effect of different membranes based on chitosan against strains of S. aureus isolated
from infected ulcers. The study found that seven of nine strains of S. aureus are sensitive
to rifampin and the least eight of nine strains were multiresistant to more than ten
antibiotics. All chitosan-based membranes confirm its antimicrobial effect on direct contact
with an increase in its diameter. The contact area of the membranes is increased according
to the concentration of chitosan. The highest average area increase was the chitosan
membranes with honey and glycerin, 88.32%. Chitosan membranes have shown their
effectiveness against S. aureus strains of clinical origin. Thus, these materials can be applied
for the treatment of chronic ulcers without toxic hazards and resistance caused by
antibiotics.
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1. Introduction
Staphylococcus aureus is an infectious microorganism that can be both community- and hospital-
acquired. Among the microorganisms causing nosocomial infections, it is second in prevalence
(10.6%) of infection in surgical areas, intensive care, and pediatric areas [1, 2]. Similarly, this
Gram-positive pathogen is the infectious agent in a broad spectrum of diseases from skin
abscesses,  dermatitis,  surgical  wounds,  bacteremia,  and  osteomyelitis.  The  antimicrobial
treatment of S. aureus infections has become more complicated by the increase of a broad spectrum
of antibiotics and the development of resistant strains.
Chitosan is a cationic linear polysaccharide composed of glucosamine and N-acetyl glucosa-
mine units linked by β (1-4) glucoside bonds [3]. This polymer is biodegradable and has
antimicrobial activity against S. aureus, Escherichia coli, Salmonella typhimurium, and fungi [4].
The antimicrobial effect of chitosan is attributed to positive charges of the polymer chain. Thus,
by increasing the amount of amino groups protonated, antimicrobial activity is enhanced by
affecting the permeability of the bacterial cell wall. Due to its antimicrobial activity, it has been
used in food preservation as antimicrobial coating of bread, fruit, vegetables, eggs, and various
meat products. Because of their lack of toxicity and allergenicity, chitosan is a biomaterial with
pharmaceutical and medical applications. Thus, chitosan has been used in health care products
such as curing agent, dressings, skin grafts [3], hemostat, and drug carrier [5]. These bioma-
terials can be prepared in the form of hydrogels, membranes, and sponges.
The skin surface is characterized by a slightly acidic pH that favors the development of some
bacteria [6]. However, in an open wound, within the first 24–48 h can be found Streptococcus,
S. aureus, and Pseudomonas aeruginosa and then, between days 5 and 7, the bacteria found were
Klebsiella and Escherichia coli [7].
Skin infections affect the epidermis, subcutaneous tissue, and muscle. Some of them require
hospital admission for antimicrobial or surgical treatment. Depending on their severity, they
have been associated with increased hospital stays and medical costs because traditional
antibiotic treatments require long periods [8]. An alternative to antibiotics is curing materials
with bioactive components. These dressings should ideally maintain a moist environment, act
as antimicrobials to prevent secondary infections, remove exudate, and promote tissue
regeneration [9, 10] One group evaluated the antimicrobial action of cotton textile impregnated
with chitosan against bacteria isolated from the skin and found that chitosans of low- and high-
molecular weight showed effective inhibition of S. aureus [11]. Another studied the effect of
chitosan in antimicrobial ultrastructural organization of clinical S. aureus strains and found
changes in its cell and cytoplasmic membrane. Similarly, Woo et al. [12] developed a bilayer
scaffold from chitosan with TiO2 that showed high reduction in viable S. aureus. To our
knowledge, there are no studies on the application of chitosan membranes against S. aureus
isolated from infected ulcers of the patients hospitalized. This chapter deals with the prepa-
ration and evaluation of the effect of different membranes based on chitosan against S. aureus
strains of clinical origin. All chitosan membranes were prepared by solvent evaporation and
the antimicrobial activity was evaluated by the agar diffusion technique.
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2. Experimentation
2.1. Chitosan
Chitosan was obtained by thermo-alkaline hydrolysis of chitin, which was recovered by lactic
fermentation of shrimp waste. The chitin was demineralized (0.1 M HCl at 25°C for 4 h) and
deproteinized (4.5% NaOH at 65°C for 4 h). Afterward, purified chitin was deacetylated (40%
NaOH at 110°C for 2 h) to obtain chitosan, according to reported methodologies [13]. Chitosan
was washed until a neutral pH was reached and dried at 50°C. The purity of the chitosan was
verified based on its moisture and ash content by method given in reference [14].
Degree of deacetylation of chitosan was determined by a spectrophotometric method reported
by Liu et al. [15]. Briefly, two standard solutions were prepared; D-glucosamine (7.49 mM) and
N-acetylglucosamine (0.49 mM), from these, working solutions were prepared to obtain a 12-
point line of different concentrations. The absorbance of the standard solutions and samples
were read at 201 nm in a UV-Vis spectrophotometer (Genesys 10 UV, Madison, IA, USA).
Finally, the degree of deacetylation was calculated with the following equation, %DD = (161.1
× A × V – 0.0218m)/(3.361m – 42.1 × A × V), where, A is the absorbance of the sample, V is the
volume of dilution, and m is the amount of sample in mg.
The molecular weight of chitosan was determined as proposed by Solis et al. [16], based on the
intrinsic viscosity, according to Mark-Houwink´s equation n = KMva. Where, the reported
values of K and a for chitosan in HAc 0.3 M and NaAc 0.2 M at 30°C are 0.074 and 0.76 mg,
respectively. An Ubbelohde capillary viscometer immersed in water bath at 30 ± 0.01°C was
used. The falling time of solvent (t0) and of five polymer solutions of known concentrations
(ti) was measured.
Chitosan was identified by Fourier Transform Infrared Spectroscopy (FTIR) according to the
methodology given in reference [17], with some modifications. The spectral resolution was
of 4 cm−1 with 64 scans in a range of 600–4000 cm−1 using a Thermo Scientific (Nicolet5s,
Madison, IA, USA) infrared spectrometer.
2.2. Chitosan membranes
Six chitosan based formulations using 1% acetic acid were prepared. Three pure chitosan
solutions (1, 2, and 3%), another of 2% chitosan with glycerin (five drops per 100 ml) and
two more solutions of 2% chitosan using honey (95:5, v/v) with and without glycerin. For
the last two solutions, honey was diluted in distilled water (80:20, v/v) and homogenized by
stirring.
All chitosan membranes were prepared by solvent evaporation. For this, solutions of each
formulation were poured into polypropylene plates (10 ml in each mold) and dried at 40°C for
24 h in an oven (Felisa, Zapopan, Jalisco, Mexico). Lastly, the films were removed from the
mold and stored in sterile plastic bags until use.
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2.3. Collection and conservation of the sample
Between June and December 2015, a descriptive and cross-sectional study was conducted in
order to evaluate the effect of chitosan membranes against S. aureus strains isolated from skin
ulcers. Patients and involved personnel confirmed their participation by giving their consent.
The samples were obtained from the center of the ulcer by a medical epidemiologist. For this,
a Stuart medium swab collection system (COPAN Transystem, Brescia, Italy) was used. The
labeled samples were transported in a container to a certified microbiology laboratory for
processing within the same hour.
2.4. Phenotypic identification and sensitivity tests
For microbial isolation and identification, the samples were inoculated by cross-streaking on
MacConkey agar for Gram-negative bacterium and trypticase soy agar (TSA) for culture
collection. Mannitol salt agar was used for Gram-positive bacterium and Biggy agar for fungi
inoculated by streaking. Next, the plates were incubated at 37°C for bacteria and 30°C for fungi
for 24 h. Later, macroscopic characteristics of colony-forming units (CFU) were analyzed.
For the identification of microorganisms, a broth microdilution method was used, with an
inoculation Prompt™ system precision wand. Isolated colonies were emulsified in Prompt™
innoculation bottles for an equivalent concentration of 0.08 with the McFarland standard. Next,
100 μl per well were deposited in the SIEMENS microplates from a MicroScan RENOK panel
which was incubated at 37°C for 24 h. Specifically, type 33 plates (B1017-211) were used for
Gram-positive bacteria and type 44 (B1017-305) for Gram-negative bacteria. Later, each plate
was read for the identification of studied microorganisms using a LabPro Command Center
software. Antibiotic sensitivity was performed simultaneously with phenotypic identification
using a RENOK MicroScan panel. The MIC (Minimum Inhibitory Concentration) was deter-
mined according to the CLSI (Clinical and Laboratory Standards Institute) criteria for each
antibiotic. The studied antibiotics were oxacillin, gentamicin, tetracycline, daptomycin,
ampicillin, erythromycin, penicillin, nitrofurantoin, vancomycin, levofloxacin, moxifloxacin,
ciprofloxacin, linezolid, ceftriaxone, Sinercid, clindamycin, rifampin, amoxicillin/clavulanate
k, trimethoprim/sulfamethoxazole, and ampicillin/sulbactam.
2.5. Sensitivity tests with chitosan membranes
The sensitivity test for S. aureus was performed by Kirby-Bauer’s agar diffusion method [18].
From each of the identified bacterial isolates a micro-dilution was prepared in Prompt™
inoculation bottle. Afterward, plates with Muller Hinton agar were inoculated with a sterile
swab and dispersed by streaking.
Chitosan based membranes were cut into 16 mm diameter discs and placed in triplicate on the
inoculated agar with sterile forceps, ensuring direct contact between both surfaces. Each agar
also included two blank controls that consisted of Whatman # 1 paper; one was impregnated
with 1% acetic acid and the other with 0.9% sodium chloride. Plates were incubated at 37°C
for 24 h. Lastly, the antimicrobial effect of chitosan was evident by observing the existence of
inhibition zones below the membranes and inhibition halos around each membrane.
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3. Results and discussion
3.1. Chitosan characterization
The ash content of chitosan is an indication of its purity. For chitosan with 9.42 ± 0.07% moisture,
the average ash contents are 0.37 ± 0.02%. The range of ash content is 0.08% for langoustine
obtained chitosan [19] and 4.0% to crab obtained chitosan [20], whereas for chitosan obtained
from shrimp, the range is from 0.070 [21] to 0.832% [22]. Variations in ash content are due to
the location of origin, as well as the purification and thermos-alkaline hydrolysis of chitin.
The molecular weight of chitosan determines its functional properties and its antimicrobial
activity. This study found that the average molecular weight of chitosan was 119.48 kDa,
estimated based on the intrinsic viscosity. With this value, chitosan can be classified as a low
molecular weight (50–190 kDa) material. Therefore, the molecular weight is a reflection of the
process conditions used to obtain chitosan from the purification and thermo-alkaline deace-
tylation of chitin. Other investigations have reported molecular weights for shrimp obtained
chitosan of 136 [23], 180 [24], and 1260 kDa [25]. While the values reported for chitosan obtained
from crab shells vary from 1240 [26] to 483 kDa [27]. For fungal chitosan, reports show low
molecular weight, from 41 [24] to 110–150 kDa [25]. Davoodbasha et al. [28] conducted
antimicrobial tests with commercial chitosan 100–300 kDa. Hernández-Ochoa et al. [29] also
studied the antimicrobial activity of commercial chitosan with different molecular weight (low:
50–190 kDa, medium: 190–310 kDa and high: 310–375 kDa) finding satisfactory results with
the lower molecular weight.
For the degree of deacetylation of chitosan, an average value of 84.59 ± 0.87% (n = 6) was found,
similar to that reported in other studies; 85 [30], 82 [31], 83 [20], and 73.52% [32] varying
depending on the source of chitin and the deacetylation conditions. To determine the degree
of deacetylation, a variety of methods have been employed; however, among the most
repetitive are the spectrophotometric and potentiometric methods and FTIR [27]. The degree
of deacetylation has a strong impact on the antimicrobial activity of chitosan, mostly because
its increase raises its solubility. Therefore, a greater number of amino groups with positive
charge can be obtained, which are responsible for interacting with the cell wall charge of
microorganisms [33].
The FTIR technique made it possible to identify the functional groups in the chitosan molecule
(Figure 1). At 881.96 cm−1, a characteristic band of the stretching of the glycosidic bond can be
observed; also at 1055.62 and 1028.60 cm−1 the stretching of C─O can be seen. It is possible to
observe the bending band N─H of the primary amide formed during deacetylation at 1545.72
cm−1 and the amine group at 1626.76 cm−1. At the position of 2884.84 cm −1 the stretching of C─H
and at 2962.02 cm−1 the tense vibration from group C─H can be observed. Ultimately, OH and
N─H were identified at 3274.61 and 3359.51 cm−1, respectively. These results are similar to those
reports given by references [32, 34]. As reported by Shigemasa et al. [35], errors in band
intensity can occurred at positions 1640 and 3450 cm−1 due to the effect of water absorption.
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Figure 1. FTIR spectra of powdered chitosan.
3.2. Preparation of chitosan membranes
Dissolved chitosan is capable of forming a membrane due to the evaporation of the solvent, as
well as forming intra and intermolecular hydrogen bonds between the chitosan polymer
chains [36]. Chitosan membranes were prepared using pure chitosan and a mix of chitosan
with glycerin or honey. All membranes were transparent, uniform, and smooth at the surface
and with hard texture when chitosan concentration was increased. Pure chitosan membranes
show a very pale yellow color and membranes containing honey show a brown tone. All
membranes were easily removed from the polyethylene plates with 9.5 cm in diameter, and
thickness depending on the concentration of chitosan, found in the range of 0.0131 ± 0.0021
and 0.0339 ± 0.0034 mm for 1 % and 3 %, respectively.
3.3. Phenotypic identification of microorganisms
From patients hospitalized for various reasons in a regional hospital located in northwestern
Mexico, 23 infected skin ulcers derived from toes, sacral parts, coccyx, arm, and leg stumps
were analyzed. The age range of the patients was from 43 to 96 years. Among the isolated and
identified strains were S. aureus, Proteus mirabilis, Candida albicans, E. coli, Enterobacter aerogenes,
Morganella morganii, P. aeruginosa, and Klebsiella pneumoniae. From all identified strains nine
(29.03%) were S. aureus. The incidence of S. aureus in ulcers with mild type infection is 80–90%
and in moderate to severe infections, it is 66% [37]. According to Barberán and Fariñas [38],
S. aureus has been the cause of 40% of infections in skin and soft tissue [8]. Mention that the
microorganisms with higher incidence in skin lesions and that increase resistance to antibiotics
are E. coli, K. pneumoniae, P. mirabilis, Enterobacter cloacae, Serratia marcescens, M. morganii,
Acinetobacter baumannii, and P. aeruginosa. Barberán and Fariñas [38], report that Propionibac‐
terium acnes and S. aureus are some of the most common skin pathogens. Figure 2, left, shows
the development of S. aureus on mannitol salt agar, medium that enables the growth of Gram-
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positive bacteria and inhibits the growth of Gram-negative. Figure 2, right, presents a
microplate which includes the identification phase and the antibiogram phase with dilutions
of the antibiotics.
Figure 2. S. aureus growth in mannitol salt agar and microplate for identification with antibiogram.
Antibiogram UD-001 UD-002 UD-020 UD-021 UD-023 UD-024 UD-025 UD-029 UD-030
Oxacillin R ˃2 S < 0.25 S < 0.25 R ˃ 2 R ˃ 2 R ˃ 2 R ˃ 2 R ˃ 2 R ˃ 2
Gentamicin S < 4 S < 4 S < 4 R ˃ 8 R ˃ 8 S < 4 R ˃ 8 S < 4 S < 4
Tetracycline S < 4 S < 4 S < 4 R ˃ 8 R ˃ 8 R ˃ 8 S < 4 S < 4 S < 4
Daptomycin R ˃ 4 R ˃4 R ˃4 R ˃ 4 R ˃ 4 R ˃ 4 S < 0.5 R ˃ 4 S < 0.5
Ampicillin R ˃ 8 R ˃ 8 S < 2 R ˃ 8 R ˃ 8 R ˃ 8 R ˃ 8 R ˃ 8 R ˃ 8
Erythromycin R ˃ 4 R ˃4 R ˃4 R ˃ 4 R ˃ 4 R ˃ 4 R ˃ 4 R ˃ 4 R ˃ 4
Penicillin S < 0.03 R ˃ 8 R ˃ 8 R ˃ 8 R ˃ 8 R ˃ 8 R ˃ 8 R ˃ 8 R ˃ 8
Nitrofurantoin R ˃ 64 S < 32 S < 32 S< 32 R ˃ 64 R ˃ 64 S < 32 S < 32 S < 32
Vancomycin S < 0.25 S < 0.25 R ˃ 16 S < 0.25 S < 32 R ˃ 16 R ˃ 16 R ˃ 16 R ˃ 16
Levofloxacin R ˃ 4 S < 1 R ˃ 4 R ˃ 4 R ˃ 4 R ˃ 4 R ˃ 4 R ˃ 4 R ˃ 4
Moxifloxacin R ˃ 4 S < 0.5 R ˃ 4 R ˃ 4 R ˃ 4 R ˃ 4 R ˃ 4 R ˃ 4 R ˃ 4
Ciprofloxacin R ˃ 2 S < 1 R ˃ 4 R ˃ 2 R ˃ 2 R ˃ 2 R ˃ 2 R ˃ 2 R ˃ 2
Linezolid S < 1 S < 1 R ˃ 4 R ˃ 4 R ˃ 4 S < 1 S < 1 R ˃ 4 R ˃ 4
Ceftriaxone R ˃ 32 S < 8 S < 8 S < 8 R ˃ 32 R ˃ 32 R ˃ 32 S < 8 R ˃ 32
Synercid S < 0.5 S < 0.5 R ˃ 2 R ˃ 2 R ˃ 2 S < 0.5 S < 0.5 S < 0.5 S < 0.5
Clindamycin R ˃ 4 S < 0.5 S < 0.5 R ˃ 4 R ˃ 4 R ˃ 4 R ˃ 4 R ˃ 4 R ˃ 4
Rifampin S < 1 S < 1 S < 1 R ˃ 2 R ˃ 2 S < 1 S < 1 S < 1 S < 1
Amoxicillin/K
clauvulanato
R ˃ 4/2 S < 4/2 R ˃ 4/2 R ˃ 4/2 R ˃ 4/2 R ˃ 4/2 R ˃ 4/2 R ˃ 4/2 R ˃ 4/2
Trimethoprim/
sulfamethoxazole
S < 0.5/9.5 S < 0.5/9.5 R ˃ 2/38 R ˃ 2/38 R ˃ 2/38 S < 0.5/9.5 R ˃ 2/38 R ˃ 2/38 S < 0.5/9.5 
Ampicillin/
sulbactam
R ˃ 16/8 R ˃ 16/8 S < 8/4 R ˃ 16/8 R ˃ 16/8 S < 8/4 S < 8/4 S < 8/4 S < 8/4
R, resistant; S, sensitive.
Table 1. Antibiogram of chronic ulcers from S. aureus isolates.
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3.4. S. aureus sensitivity to antibiotics
Table 1 shows the minimum inhibitory “in vitro” amount of twenty antibiotics against nine
strains of S. aureus studied with a RENOK MicroScan panel. Specifically, seven of the nine
S. aureus strains are sensitive to rifampin (MIC < 1 μ/ml), while the least effective antibiotics
were ampicillin (MIC ˃ 8 μ/ml), erythromycin (MIC ˃ 4 μ/ml), penicillin (MIC ˃ 8 μ/ml),
levofloxacin (MIC ˃ 4 μ/ml), moxifloxacin (MIC ˃ 4 μ/ml), ciprofloxacin (MIC ˃ 2 μ/ml), and
clavulanate amoxycillin (MIC ˃ 4/2 μ/ml). In addition, eight of the nine strains were detected
to be multiresistant to more than ten antibiotics. Additionally, one isolated showed sensitivity
to vancomycin, while another was sensitive to 15 of the 20 studied antibiotics.
Figure 3 shows that most strains are resistant to the most commonly used antibiotics. All
isolates were resistant to erythromycin. Only one of the nine strains showed sensitivity toward
ampicillin, penicillin, levofloxacin, ciprofloxacin, and amoxicillin.
Figure 3. Antibiotic sensitivity and resistant toward S. aureus.
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The most commonly used antibiotics for S. aureus treatments are vancomycin, linezolid,
daptomycin, tigecycline, rifampin, clindamycin, cloxacillin, clindamycin, cotrimoxazol, and
doxycycline [1]. Daptomycin has superior bactericidal action than other drugs against S. aureus
[38]. Chirinos-Saldaña et al. [39] found that S. aureus isolated from conjunctivitis shows high
sensitivity toward vancomycin, ciprofloxacin, and gentamicin. Antibiotic resistance is gener-
ated due to prolonged and inappropriate use of antibiotics [39]. Furthermore, if the bacterial
population density in the infection is high, S. aureus can become resistant to most antibiotics
used in monotherapy [40].
3.5. S. aureus sensitive chitosan membranes
The “in vitro” antimicrobial activity assays with chitosan membranes for S. aureus were carried
out by the agar diffusion method. Figure 4 presents the absence of microbial growth below the
membranes. It was also observed that no inhibition halo or clear zones were formed around
the membrane explained because chitosan is unable to diffuse through agar. However, chitosan
membranes added with honey presented a small zone of inhibition, confirming that chitosan
only has antimicrobial effect by direct contact and cannot migrate into the agar. Likewise,
microbial growth occurred in both blank controls with acetic acid and sodium chloride, which
means that the antimicrobial effect cannot be attributed to these chemicals.
Figure 4. S. aureus susceptibility to chitosan membranes by agar diffusion method. Chitosan 1% (a), chitosan 2% (b),
chitosan 3% (c), chitosan 2% + gly (d), chitosan 2% + honey (e), and chitosan 2% + honey + gly (f).
In a study by Hernández-Ochoa et al. [29], with S. typhimurium, S. aureus, and Listeria mono‐
cytogenes, results reported that chitosan membranes with essential oils (Cuminum cyminum and
Eugenia caryphyllata) can present inhibition halos, while for pure chitosan membranes, the
effect is shown only by direct contact.
The antimicrobial properties of chitosan mainly depend on the degree of deacetylation and
molecular weight, as well as pH and ionic strength of the medium [41]. El-tahlawy et al. [42]
and Hosseinnejad and Jafari [43] reported that low molecular weight chitosan can penetrate
into the cell and inhibits mRNA and protein synthesis. Chitosan oligomers have higher
antimicrobial effect due to their shorter chain and free amino groups from D-glucosamine [44].
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Similarly, Champer et al. [45] reported that the amount of free amino groups influence the
antibacterial properties of chitosan. Likewise, Wang et al. [46] state that all bacteria possess
negative charges; therefore, they are easily captured by the protonated amine groups of
chitosan and lose their reproductive functions and bioactivity. Acetic acid has an effect on the
solubility of the polymer and on the protonation of the amino groups.
Kim et al. [47] evaluated the antimicrobial activity of chitosan membranes of different molec-
ular weights with L. monocytogenes, E. coli, and Salmonella typhimutium and found that chitosan
with low molecular weight has better effect. No et al. [48] reported that chitosan (1671, 746,
224, and 28 kDa) and chitosan oligomers (22, 10, 7, 3, 2, and 1 kDa) can inhibit the growth of
L. monocytogenes, Bacillus megaterium, Bacillus cereus, S. aureus, and Lactobacillus bulgaricus.
Additionally, it was observed that the membranes tend to increase their diameter by staying
in contact with the agar, thus increasing the antimicrobial effect by contact. Table 2 presents
the increase in diameter and area of the membranes at the end of agar diffusion assay. For pure
chitosan membranes, it was found that an increase in size is directly proportional to its
concentration. It was also observed that the addition of glycerin or honey increases the size of
the chitosan membranes by 2%. The 2% chitosan membranes mixed with honey and glycerin
showed the greatest increase, however, bacterial growth was observed.
Membranes Increased radius (mm)a Increase in contact area (%)b
Qo 1% 9.01 ± 4.97 20.03 ± 14.90
Qo 2% 9.39 ± 6.48 30.61 ± 17.33
Qo 3% 9.70 ± 9.58 39.80 ± 25.80
Qo 2% + gly 9.74 ± 6.34 40.34 ± 17.38
Qo 2% + miel 11.20 ± 4.65 65.38 ± 20.29
Qo 2% + miel + gly 11.20 ± 4.53 88.32 ± 21.73
a8.25 mm initial radius.
b213.82 mm2 initial area.
Table 2. Comparison of the increase in radii and areas of chitosan membranes.
Vlacha et al. [49] reported that free hydroxyl groups from chitosan interact with the moist
atmosphere increasing the diameter of the membrane. Also, Zamora-Mora et al. [50] men-
tioned that pure chitosan membranes show a higher water holding capacity due to the
hydrophilicity of the chitosan. According to Estrada et al. [51], honey potentiates the antimi-
crobial activity of chitosan due to chemical action of its components; hydrogen peroxide,
organic acids and flavonoids, nectar, pollen, and propolis. For Grade et al. [52], plasticizers
provide flexibility to the membranes, but weaken the intermolecular forces and cause the
penetration of water through the membrane increasing its size [23].
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4. Conclusion
Different types of chitosan-based membranes mixed with glycerol and honey were developed
and characterized. These membranes showed antimicrobial activity against S. aureus of clinical
origin. Additionally, strains of S. aureus isolated from infected ulcers were found to have
multidrug resistance to antibiotics. For future research where these materials will be applied
in the treatment of chronic ulcers, it is important to recognize that the antimicrobial effect is
given by direct contact in order to ensure that ulcers are completely covered with the mem-
branes. These materials are an alternative for controlling intrahospital microorganisms
without toxic hazards from antibiotics.
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